Status:
UNKNOWN
The Influence of Genetic Predisposition on Outcome After Catheter Ablation of Atrial Fibrillation.
Lead Sponsor:
Deutsches Herzzentrum Muenchen
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
18+ years
Brief Summary
Catheter ablation is an established standard therapy in interventional treatment of atrial fibrillation.The trial investigates the influence of genetic risk for the recurrence of atrial fibrillation a...
Detailed Description
Catheter ablation is an established standard therapy in interventional treatment of atrial fibrillation. electric isolation of the pulmonary veins, from which atrial fibrillation is originating in mos...
Eligibility Criteria
Inclusion
- patients planned for primary ablation due to paroxysmale or persistent atrial fibrillation
- written informed consent
Exclusion
- patients under 18 years of age or patients not able to give informed consent
- prior left atrial ablation
Key Trial Info
Start Date :
November 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2023
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT04753541
Start Date
November 1 2020
End Date
June 1 2023
Last Update
February 15 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Deutsches Herzzentrum Muenchen
Munich, Germany, 80636